[go: up one dir, main page]

MX2010000483A - Semillas y marcadores para usarse en formacion de imagen. - Google Patents

Semillas y marcadores para usarse en formacion de imagen.

Info

Publication number
MX2010000483A
MX2010000483A MX2010000483A MX2010000483A MX2010000483A MX 2010000483 A MX2010000483 A MX 2010000483A MX 2010000483 A MX2010000483 A MX 2010000483A MX 2010000483 A MX2010000483 A MX 2010000483A MX 2010000483 A MX2010000483 A MX 2010000483A
Authority
MX
Mexico
Prior art keywords
imaging
markers
seeds
casing
contrast
Prior art date
Application number
MX2010000483A
Other languages
English (en)
Inventor
Steven J Frank
Karen Martirosyan
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of MX2010000483A publication Critical patent/MX2010000483A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1027—Interstitial radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/508—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/06—Cobalt compounds
    • C07F15/065—Cobalt compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3954—Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
    • A61N2005/1023—Means for creating a row of seeds, e.g. spacers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

Se provee un marcador de contraste que tiene una envoltura y un novedoso agente de contraste de MRI que comprende complejos de metal dispuestos alrededor, dentro o adyacentemente a la envoltura; se pueden colocar tales marcadores de contraste en un filamento, con o sin semilla de terapia, para producir un filamento sembrado útil para formar imágenes y en conexión con braquiterapia.
MX2010000483A 2007-07-11 2008-07-11 Semillas y marcadores para usarse en formacion de imagen. MX2010000483A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94915707P 2007-07-11 2007-07-11
PCT/US2008/069861 WO2009009760A1 (en) 2007-07-11 2008-07-11 Seeds and markers for use in imaging

Publications (1)

Publication Number Publication Date
MX2010000483A true MX2010000483A (es) 2010-03-26

Family

ID=40229098

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010000483A MX2010000483A (es) 2007-07-11 2008-07-11 Semillas y marcadores para usarse en formacion de imagen.

Country Status (12)

Country Link
US (3) US8529872B2 (es)
EP (1) EP2170463B1 (es)
JP (1) JP5577245B2 (es)
CN (1) CN101827631B (es)
AU (1) AU2008274922B2 (es)
BR (1) BRPI0813640B1 (es)
CA (1) CA2692938C (es)
ES (1) ES2539767T3 (es)
IL (1) IL203239A (es)
MX (1) MX2010000483A (es)
WO (1) WO2009009760A1 (es)
ZA (1) ZA201000360B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2692938C (en) 2007-07-11 2014-06-17 Board Of Regents, The University Of Texas System Seeds and markers for use in imaging
US20100254584A1 (en) * 2009-04-07 2010-10-07 Siemens Corporation Automated method for assessment of tumor response to therapy with multi-parametric mri
NL2005040C2 (nl) * 2009-11-20 2011-05-24 Dirk Peter Leenheer Werkwijze voor het maken van een numeriek drie-dimensionaal model van een structuur uit zachte en harde delen, drie-dimensionaal model en drager.
CN102686275B (zh) 2009-12-28 2015-05-13 皇家飞利浦电子股份有限公司 用于以经由形状感测的追踪为特征的近距离疗法的方法和设备
US20110188720A1 (en) * 2010-02-02 2011-08-04 General Electric Company Method and system for automated volume of interest segmentation
US20110301456A1 (en) * 2010-06-07 2011-12-08 Malignext Targeting Technologies, Inc. Tissue Marking for Lesion Removal
MX356514B (es) 2011-01-20 2018-05-30 Univ Texas Marcadores de formación de imagen por resonancia magnética, sistemas de suministro y extracción, y métodos de fabricación y uso de los mismos.
US8798716B1 (en) * 2011-11-03 2014-08-05 Solstice Corporation Fiducial markers and related methods
US9770304B2 (en) 2012-02-01 2017-09-26 Koninklijke Philips N.V. Multimodal fiducial marker and marker arrangement
US9265423B2 (en) * 2012-05-08 2016-02-23 Siemens Medical Solutions Usa, Inc. Metallic object MR imaging quality control system
CA2888993A1 (en) * 2012-10-26 2014-05-01 Viewray Incorporated Assessment and improvement of treatment using imaging of physiological responses to radiation therapy
WO2014092570A1 (en) * 2012-12-12 2014-06-19 Nucletron Operations B.V. A brachytherapy instrument, an imaging system and a method of image acquisition
US10245446B2 (en) 2013-03-14 2019-04-02 University Of Iowa Research Foundation Marker-flange for MRI-guided brachytherapy
DE102014204381B4 (de) * 2014-03-11 2017-03-23 Siemens Healthcare Gmbh Planung einer Brachytherapie-Behandlung aufgrund von Magnetresonanz-Bilddaten mit hyperintens dargestellten Bereichen
DE102014218454A1 (de) * 2014-09-15 2016-03-17 Siemens Aktiengesellschaft Vorrichtung, medizinisches Instrument und Verfahren zur Gewinnung eines räumlichen Bildes eines medizinischen Instrumentes mit einem Magnetresonanztomografiegerät
US10159850B2 (en) * 2016-01-06 2018-12-25 Covidien Lp Brachytherapy clip and applicator
WO2018049518A1 (en) * 2016-09-14 2018-03-22 Sunnybrook Research Institute Method for manufacturing biocompatible coated magnetic seed markers
EP3589189A1 (en) * 2017-03-03 2020-01-08 Massachusetts Institute of Technology Methods and systems for quantitative monitoring of in vivo tumor oxygenation
US11253727B2 (en) 2017-10-18 2022-02-22 Sunnybrook Research Institute Magnetic resonance visible markers for magnetic resonance imaging guided brachytherapy
US11202888B2 (en) 2017-12-03 2021-12-21 Cook Medical Technologies Llc MRI compatible interventional wireguide
US10859508B2 (en) 2018-05-29 2020-12-08 Board Of Regents, The University Of Texas System Devices and methods for evaluation of deformable image registration (DIR) systems
US11737851B2 (en) 2018-06-28 2023-08-29 Cook Medical Technologies Llc Medical devices for magnetic resonance imaging and related methods
CN113289269B (zh) * 2021-06-01 2022-02-15 南方医科大学南方医院 一种适用于乳腺癌术后疤痕显影标记线装置
NL2030157B1 (en) * 2021-12-16 2023-06-28 Nucletron Operations Bv Marking arrangement, medical device, and system for reconstructing a planned trajectory
US12487299B2 (en) 2022-06-20 2025-12-02 Shanghai United Imaging Healthcare Co., Ltd. Magnetic resonance imaging devices and radiation therapy systems including the magnetic resonance imaging devices

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5342283A (en) * 1990-08-13 1994-08-30 Good Roger R Endocurietherapy
US6333971B2 (en) * 1995-06-07 2001-12-25 George S. Allen Fiducial marker
US5713828A (en) * 1995-11-27 1998-02-03 International Brachytherapy S.A Hollow-tube brachytherapy device
CN2290358Y (zh) * 1996-11-18 1998-09-09 深圳奥沃国际科技发展有限公司 立体定位装置
IT1304501B1 (it) 1998-12-23 2001-03-19 Bracco Spa Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
US6575888B2 (en) * 2000-01-25 2003-06-10 Biosurface Engineering Technologies, Inc. Bioabsorbable brachytherapy device
US6534039B2 (en) * 2000-07-21 2003-03-18 James F. Hainfeld Extended organic cobalt and nickel magnetic complexes
US6521773B1 (en) * 2000-07-21 2003-02-18 James F. Hainfeld Extended organic cobalt and nickel magnetic complexes
US7776310B2 (en) * 2000-11-16 2010-08-17 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
US6514193B2 (en) * 2000-11-16 2003-02-04 Microspherix Llc Method of administering a therapeutically active substance
US7022086B2 (en) * 2002-05-21 2006-04-04 Scimed Life Systems, Inc. Guidewire with encapsulated marker
KR100439962B1 (ko) * 2002-06-05 2004-07-12 한국원자력연구소 방사성 의약품용 테크네튬 또는 레늄 착물의 제조방법
US6957098B1 (en) * 2002-06-27 2005-10-18 Advanced Cardiovascular Systems, Inc. Markers for interventional devices in magnetic resonant image (MRI) systems
AU2003266655B2 (en) * 2002-09-27 2009-01-08 Nihon Medi-Physics Co., Ltd. Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
US20040158118A1 (en) * 2003-02-10 2004-08-12 Drobnik Christopher D. Terminus-spacer component of a string comprising one or more spacer components and one or more implantation seeds
US20050107870A1 (en) * 2003-04-08 2005-05-19 Xingwu Wang Medical device with multiple coating layers
CN1537657A (zh) * 2003-10-22 2004-10-20 高春平 手术中放射治疗装置
CA2575649C (en) * 2006-01-25 2015-04-14 University Of Victoria Innovation And Development Corporation Lanthanide rich nanoparticles, and their investigative uses in mri and related technologies
CA2692938C (en) * 2007-07-11 2014-06-17 Board Of Regents, The University Of Texas System Seeds and markers for use in imaging

Also Published As

Publication number Publication date
EP2170463A4 (en) 2011-07-20
US20130309167A1 (en) 2013-11-21
BRPI0813640A2 (pt) 2017-05-16
JP5577245B2 (ja) 2014-08-20
US20100254897A1 (en) 2010-10-07
CN101827631B (zh) 2013-04-24
AU2008274922B2 (en) 2014-04-03
EP2170463A1 (en) 2010-04-07
IL203239A (en) 2014-03-31
ES2539767T3 (es) 2015-07-03
AU2008274922A1 (en) 2009-01-15
EP2170463B1 (en) 2015-03-18
ZA201000360B (en) 2011-03-30
US20140178297A1 (en) 2014-06-26
BRPI0813640B1 (pt) 2023-10-03
WO2009009760A1 (en) 2009-01-15
JP2010533047A (ja) 2010-10-21
CN101827631A (zh) 2010-09-08
US8529872B2 (en) 2013-09-10
CA2692938C (en) 2014-06-17
CA2692938A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
MX2010000483A (es) Semillas y marcadores para usarse en formacion de imagen.
EP2597464A3 (en) Metabolomic profiling of prostate cancer
EP2126589A4 (en) METABOLISM AND DIABETIC SUFFERING AND METHOD OF USE THEREOF
IL202317A0 (en) Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
IL186662A0 (en) Combination cancer therapy with
EP1865882A4 (en) DEGRADABLE IMPLANTABLE MEDICINE PRODUCTS
IL215373A (en) Spink 1 as a prostate cancer marker and its use @
EP2046424A4 (en) METHODS AND DEVICES FOR STIMULATING AN ORGAN WITH THE USE OF A CROSS-CUTTING GUIDED GUIDE WIRE
NZ584630A (en) Exercise device having inelastic straps and interchangeable parts
EP2318051A4 (en) IN VITRO DIAGNOSTIC MARKERS COMPRISING CARBON NANOPARTICLES AND KITS
PT1937244T (pt) Tratamento do cancro com agonistas específicos de rxr
AU316078S (en) Surgical tissue stimulator/locator
EP2150203A4 (en) NEEDLE INSTRUMENTS AND IMPLANTABLE FRONT ASSEMBLY; KITS COMPRISING THESE COMPONENTS; AND METHODS OF USE
ZA200906063B (en) Seed treatment with PRF
GB0718167D0 (en) Cancer marker and therapeutic target
EP2109432A4 (en) PATIENT REPOSITIONING AND LIMBING EQUIPMENT SYSTEM
IL196184A0 (en) Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
EP2217049A4 (en) MAGNETIC SCREEN BODY AND MAGNETIC SCREEN SPACE
ZA201005692B (en) The use of nickel in agriculture and horticulture
IT1398773B1 (it) Sequenze oligonucleotidiche inibitrici dell'espressione della chimera ciclina d1/trop2 e loro uso in campo medico.
GB0721698D0 (en) Moldboard positioning assembly and use thereof
EP2493917B8 (en) Breast tumor markers and methods of use thereof
PL1858929T3 (pl) Diagnostyka raka gruczołu krokowego
EP1917277A4 (en) BRAZING HUMAN LYMPHOMA AND LEUKEMIA CANCER CELLS, AND TCR-ACTIVATED NORMAL HUMAN CELLS BY DOPAMIN D1R AGONISTS
HK1117229A (en) Diagnostic markers of breast cancer treatment and progression and methods of use thereof

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM.*

FG Grant or registration